{"favorite_id": 3168, "calc_type": "calculator", "dosing": false, "full_title_en": "Karnofsky Performance Status Scale", "short_title_en": "Karnofsky Scale", "medium_description_en": "Determines ability of patient to tolerate chemotherapy.", "short_description_en": "Chemotherapy tolerance.", "before_use": "", "instructions_en": "<p>For patients &ge; 16 years old. Useful to use over time to track disease progression.</p>", "slug": "karnofsky-performance-status-scale", "logic_language": "javascript", "md5": "8f659b3d21e9e26f9a09e2e76746d829", "cmeVersion": null, "cmeReleaseDate": null, "cmeEndDate": null, "cmeLastReviewed": null, "publishedAt": "2022-04-21T20:29:13.997Z", "vuid": "598271b5-040d-49dd-a688-54f4c1b8da6d", "versionNumber": 1, "isVisibleInListView": true, "disabled": false, "replacement_calc_id": null, "disabled_reason": null, "search_abbreviation_en": ["chemo", "chemotherapy", "ability", "special care", "KPS", "KPSS", "Karnofsky Performance Status", "Karnofsky Performance Status Scale", "Karnofsky Performance Scale", "Karnofsky", "performance status", "cancer performance status", "status scale", "status"], "seo": {"meta_description_en": "The Karnofsky Performance Status Scale determines ability of patient to tolerate therapies in serious illness, specifically for chemotherapy.", "keywords_en": "karnofsky, chemo, performance status, cancer performance status, status scale, KPS, KPSS, Karnofsky Performance Status, Karnofsky Performance Status Scale, Karnofsky Performance Scale"}, "content": {"reviewer": {"expert_name": []}, "related_resources": {"mdcalc_rating": [], "guidelines": [], "teaching": [], "videos": [], "interests": [], "partner_contact": [], "sdm_tool": []}, "how_to_use": {"use_case_en": "<p>Patients with advancing cancer or other chronic diseases &mdash; or even frailty progression in the elderly.</p>", "pearls_pitfalls_en": "<ul>\n<li>The Karnofsky Performance Status Scale (KPS) is used extensively and for many purposes, including response to chemotherapy in cancer and chronic disease assessment.</li>\n<li>It quantifies a patient's functional abilities and impact of treatments like chemotherapy on their basic functional capacities.</li>\n<li>It is sometimes also used prognostically and to help determine treatment.</li>\n</ul>", "why_use_en": "<p>Performance status is highly correlated with survival time and need for services in the home. It may also help predict ability to thrive with invasive and intensive treatment.</p>"}, "next_steps": {"advice_en": "<p>The Karnofsky Performance Status Scale is clearly useful to clinicians, and either this or another functional status scale should be used to improve understanding of patient needs and abilities, as well as potentially to prognose.</p>", "management_en": "<p>We are unaware of validated management algorithms using the Karnofsky Scale.</p>", "critical_actions_en": "<p>The Karnofsky Scale and other performance scales should be used in the holistic assessment of cancer patients, though its accuracy as a prognostic tool in individual cases is not yet well proved.</p>"}, "about": {"formula_en": "<div class=\"table-responsive\">\n<table class=\"table table-bordered table-hover\">\n<tbody>\n<tr>\n<th>Description</th>\n<th>Points assigned*</th>\n<th>Description</th>\n</tr>\n<tr>\n<td>Normal no complaints; no evidence of disease.</td>\n<td>100</td>\n<td rowspan=\"3\">Able to carry on normal activity and to work;<br>no special care needed.</td>\n</tr>\n<tr>\n<td>Able to carry on normal activity; minor signs or symptoms of disease.</td>\n<td>90</td>\n</tr>\n<tr>\n<td>Normal activity with effort; some signs or symptoms of disease.</td>\n<td>80</td>\n</tr>\n<tr>\n<td>Cares for self; unable to carry on normal activity or to do active work.</td>\n<td>70</td>\n<td rowspan=\"3\">Unable to work; able to live<br>at home and care for most personal needs;<br>varying amount of assistance needed.</td>\n</tr>\n<tr>\n<td>Requires occasional assistance, but is able to care for most of his personal needs.</td>\n<td>60</td>\n</tr>\n<tr>\n<td>Requires considerable assistance and frequent medical care.</td>\n<td>50</td>\n</tr>\n<tr>\n<td>Disabled; requires special care and assistance.</td>\n<td>40</td>\n<td rowspan=\"5\">Unable to care for self;<br>requires equivalent of institutional or hospital care;<br>disease may be progressing rapidly.</td>\n</tr>\n<tr>\n<td>Severely disabled; hospital admission is indicated although death not imminent.</td>\n<td>30</td>\n</tr>\n<tr>\n<td>Very sick; hospital admission necessary; active supportive treatment necessary.</td>\n<td>20</td>\n</tr>\n<tr>\n<td>Moribund; fatal processes progressing rapidly.</td>\n<td>10</td>\n</tr>\n<tr>\n<td>Dead.</td>\n<td>0</td>\n</tr>\n</tbody>\n</table>\n<p>*% Survival correlates with points assigned.</p>\n</div>", "more_info_en": "<p>The lower the Karnofsky Scale, the worse the prognosis:</p>\n<ul>\n<li>Unable to tolerate therapies</li>\n<li>Survival rates decrease</li>\n</ul>\n<p>Karnofsky vs. <calculator id=\"3170\">ECOG/Zubrod Scores</calculator></p>\n<div class=\"table-responsive\">\n<table class=\"table table-bordered table-hover\">\n<tbody>\n<tr>\n<th style=\"width: 40%;\"><calculator id=\"3170\">ECOG PERFORMANCE STATUS</calculator></th>\n<th style=\"width: 60%;\">KARNOFSKY PERFORMANCE STATUS</th>\n</tr>\n<tr>\n<td rowspan=\"2\">0&mdash;Fully active, able to carry on all pre-disease performance without restriction</td>\n<td>100&mdash;Normal, no complaints; no evidence of disease</td>\n</tr>\n<tr>\n<td>90&mdash;Able to carry on normal activity; minor signs or symptoms of disease</td>\n</tr>\n<tr>\n<td rowspan=\"2\">1&mdash;Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work</td>\n<td>80&mdash;Normal activity with effort, some signs or symptoms of disease</td>\n</tr>\n<tr>\n<td>70&mdash;Cares for self but unable to carry on normal activity or to do active work</td>\n</tr>\n<tr>\n<td rowspan=\"2\">2&mdash;Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours</td>\n<td>60&mdash;Requires occasional assistance but is able to care for most of personal needs</td>\n</tr>\n<tr>\n<td>50&mdash;Requires considerable assistance and frequent medical care</td>\n</tr>\n<tr>\n<td rowspan=\"2\">3&mdash;Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours</td>\n<td>40&mdash;Disabled; requires special care and assistance</td>\n</tr>\n<tr>\n<td>30&mdash;Severely disabled; hospitalization is indicated although death not imminent</td>\n</tr>\n<tr>\n<td rowspan=\"2\">4&mdash;Completely disabled; cannot carry on any selfcare; totally confined to bed or chair</td>\n<td>20&mdash;Very ill; hospitalization and active supportive care necessary</td>\n</tr>\n<tr>\n<td>10&mdash;Moribund</td>\n</tr>\n<tr>\n<td>5&mdash;Dead</td>\n<td>0&mdash;Dead</td>\n</tr>\n</tbody>\n</table>\n</div>", "evidence_based_medicine_en": "", "references_list": {"Validation": [{"text": "Crooks, V, Waller S, et al. The use of the Karnofsky Performance Scale in determining outcomes and risk in geriatric outpatients. J Gerontol. 1991; 46: M139-M144.", "href": "https://www.ncbi.nlm.nih.gov/pubmed/2071835"}, {"text": "Hollen PJ, Gralla RJ, et al. Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Cancer. 1994; 73: 2087-2098.", "href": "https://www.ncbi.nlm.nih.gov/pubmed/8156514"}, {"text": "O'Toole DM, Golden AM. Evaluating cancer patients for rehabilitation potential. West J Med. 1991; 155:384-387.", "href": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1003019/"}, {"text": "Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: Reliability, validity, and guidelines. J Clin Oncology. 1984; 2:187-193.", "href": "https://www.ncbi.nlm.nih.gov/pubmed/6699671"}], "Outcomes": [], "Validations": [], "Original/Primary Reference": [{"text": "Karnofsky DA Burchenal JH. (1949). 'The Clinical Evaluation of Chemotherapeutic Agents in Cancer.' In: MacLeod CM (Ed), Evaluation of Chemotherapeutic Agents. Columbia Univ Press. Page 196.", "href": ""}], "Other References": [], "Clinical Practice Guidelines": [], "Manufacturer Website": []}}, "creator": [{"qa_en": "", "approved": null, "name": "Dr. David Karnofsky", "creator_info": {"deceased": true, "about_en": "<p>David A. Karnofsky, MD, (d. 1969) was an oncologist at Sloan-Kettering Institute for Cancer Research. He specialized in cancer chemotherapy and affiliated with the division of experimental chemotherapy.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-david-karnofsky.jpeg", "pubmedLink": "https://www.ncbi.nlm.nih.gov/pubmed/?term=Karnofsky+DA%5BAuthor%5D"}}], "contributor": {"expert_name": []}}, "input_schema": [{"type": "radio", "name": "karnofsky", "default": null, "show_points": false, "optional": false, "conditionality": null, "tips_en": "", "label_en": "<p>Patient description</p>", "option_fhir_rules": null, "options": [{"label": "Normal no complaints; no evidence of disease", "value": 100}, {"label": "Able to carry on normal activity; minor signs or symptoms of disease", "value": 90}, {"label": "Normal activity with effort; some signs or symptoms of disease", "value": 80}, {"label": "Cares for self; unable to carry on normal activity or to do active work", "value": 70}, {"label": "Requires occasional assistance, but is able to care for most of his personal needs", "value": 60}, {"label": "Requires considerable assistance and frequent medical care", "value": 50}, {"label": "Disabled; requires special care and assistance", "value": 40}, {"label": "Severely disabled; hospital admission is indicated although death not imminent", "value": 30}, {"label": "Very sick; hospital admission necessary; active supportive treatment necessary", "value": 20}, {"label": "Moribund; fatal processes progressing rapidly", "value": 10}, {"label": "Dead", "value": 0}], "mdcalc_info_concept": null}], "chief_complaint_en": ["Weakness"], "specialty_en": ["Hematology and Oncology", "Hospitalist Medicine", "Internal Medicine", "Palliative Care/Hospice", "Radiation Oncology"], "purpose_en": ["Prognosis"], "system_en": ["Oncologic"], "disease_en": ["Cancer", "Chemotherapy"], "tags": [], "versions": [], "related_calcs": [{"calcId": 3176, "short_title_en": "Lansky Scale", "slug": "lansky-play-performance-scale-pediatric-functional-status"}, {"calcId": 3170, "short_title_en": "ECOG Performance Status", "slug": "eastern-cooperative-oncology-group-ecog-performance-status"}, {"calcId": 4054, "short_title_en": "CLL-IPI", "slug": "international-prognostic-index-chronic-lymphocytic-leukemia-cll-ipi"}]}